- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00246987
A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control
April 26, 2012 updated by: Bristol-Myers Squibb
A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control
To determine the effect on glycemic control and lipid parameters of the 2.5 and 5 mg.
doses of BMS-298585 in drug naive subjects with Type 2 diabetes as an adjunct to diet and exercise.
Study Overview
Study Type
Interventional
Enrollment
341
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New South Wales
-
Canberra, New South Wales, Australia
- Local Institution
-
Sydney, New South Wales, Australia
- Local Institution
-
Wollongong, New South Wales, Australia
- Local Institution
-
-
Queensland
-
Kippa Ring, Queensland, Australia
- Local Institution
-
Meadowbrook, Queensland, Australia
- Local Institution
-
-
South Australia
-
Adelaide, South Australia, Australia
- Local Institution
-
Woodville, South Australia, Australia
- Local Institution
-
-
Tasmania
-
Launceston, Tasmania, Australia
- Local Institution
-
-
Victoria
-
Melbourne, Victoria, Australia
- Tasmania
-
-
-
-
Alberta
-
Calgary, Alberta, Canada
- Local Institution
-
Edmonton, Alberta, Canada
- Local Institution
-
-
British Columbia
-
Coquitlam, British Columbia, Canada
- Local Institution
-
-
Manitoba
-
Winnipeg, Manitoba, Canada
- Local Institution
-
-
Newfoundland and Labrador
-
Manuels, Newfoundland and Labrador, Canada
- Local Institution
-
St. John's, Newfoundland and Labrador, Canada
- Local Institution
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada
- Local Institution
-
-
Ontario
-
Markham, Ontario, Canada
- Local Institution
-
Oakville, Ontario, Canada
- Local Institution
-
Ottawa, Ontario, Canada
- Local Institution
-
Thornhill, Ontario, Canada
- Local Institution
-
Thunder Bay, Ontario, Canada
- Local Institution
-
Toronto, Ontario, Canada
- Local Institution
-
-
Prince Edward Island
-
Charlottetown, Prince Edward Island, Canada
- Local Institution
-
-
Quebec
-
Chicoutimi, Quebec, Canada
- Local Institution
-
Drummondville, Quebec, Canada
- Local Institution
-
Granby, Quebec, Canada
- Local Institution
-
Laval, Quebec, Canada
- Local Institution
-
Longueuil, Quebec, Canada
- Local Institution
-
Montreal, Quebec, Canada
- Local Institution
-
Pointe-Claire, Quebec, Canada
- Local Institution
-
St-Lambert, Quebec, Canada
- Local Institution
-
Ste-Foy, Quebec, Canada
- Local Institution
-
-
Saskatchewan
-
Regina, Saskatchewan, Canada
- Local Institution
-
Saskatoon, Saskatchewan, Canada
- Local Institution
-
-
-
-
-
Aguascalientes, Mexico
- Local Institution
-
Durango, Mexico
- Local Institution
-
-
Distrito Federal
-
Mexico City, Distrito Federal, Mexico
- Local Institution
-
-
Morelos
-
Cuernavaca, Morelos, Mexico
- Local Institution
-
-
-
-
-
Krakow, Poland
- Local Institution
-
Lodz, Poland
- Local Institution
-
Mrokow, Poland
- Local Institution
-
Warszawa, Poland
- Local Institution
-
Zabrze, Poland
- Local Institution
-
-
-
-
-
Anasco, Puerto Rico
- Local Institution
-
Ponce, Puerto Rico
- Local Institution
-
Rio Pieoras, Puerto Rico
- Local Institution
-
-
-
-
-
Changhua, Taiwan
- Local Institution
-
Taichung, Taiwan
- Local Institution
-
-
-
-
Alabama
-
Anniston, Alabama, United States
- Local Institution
-
Birmingham, Alabama, United States
- Local Institution
-
Haleyville, Alabama, United States
- Local Institution
-
Hoover, Alabama, United States
- Local Institution
-
-
Arizona
-
Fayetteville, Arizona, United States
- Local Institution
-
Hot Springs, Arizona, United States
- Local Institution
-
Mesa, Arizona, United States
- Local Institution
-
Phoenix, Arizona, United States
- Local Institution
-
Tucson, Arizona, United States
- Local Institution
-
Tulsa, Arizona, United States
- Local Institution
-
-
California
-
Concord, California, United States
- Local Institution
-
Fountain Valley, California, United States
- Local Institution
-
Long Beach, California, United States
- Local Institution
-
Los Gatos, California, United States
- Local Institution
-
Raleigh, California, United States
- Local Institution
-
Roseville, California, United States
- Local Institution
-
San Diego, California, United States
- Local Institution
-
Spring Valley, California, United States
- Local Institution
-
Tustin, California, United States
- Local Institution
-
-
Colorado
-
Colorado Springs, Colorado, United States
- Local Institution
-
Golden, Colorado, United States
- Local Institution
-
Littleton, Colorado, United States
- Local Institution
-
-
Connecticut
-
New Britain, Connecticut, United States
- Local Institution
-
-
Florida
-
Altamonte Springs, Florida, United States
- Local Institution
-
Brandon, Florida, United States
- Local Institution
-
Chipley, Florida, United States
- Local Institution
-
Coral Gables, Florida, United States
- Local Institution
-
Kissimmee, Florida, United States
- Local Institution
-
Longwood, Florida, United States
- Local Institution
-
Melbourne, Florida, United States
- Local Institution
-
New Port Richie, Florida, United States
- Local Institution
-
Ocala, Florida, United States
- Local Institution
-
Pinellas Park, Florida, United States
- Local Institution
-
-
Illinois
-
Chicago, Illinois, United States
- Local Institution
-
-
Kansas
-
Overland Park, Kansas, United States
- Local Institution
-
Shawnee Mission, Kansas, United States
- Local Institution
-
-
Kentucky
-
Lexington, Kentucky, United States
- Local Institution
-
Madisonville, Kentucky, United States
- Local Institution
-
-
Louisiana
-
Shreveport, Louisiana, United States
- Local Institution
-
-
Mississippi
-
Gulfport, Mississippi, United States
- Local Institution
-
St. Peters, Mississippi, United States
- Local Institution
-
-
Missouri
-
Chesterfield, Missouri, United States
- Local Institution
-
Kansas City, Missouri, United States
- Local Institution
-
Springfield, Missouri, United States
- Local Institution
-
-
New Jersey
-
Elizabeth, New Jersey, United States
- Local Institution
-
Toms River, New Jersey, United States
- Local Institution
-
-
New York
-
Endwell, New York, United States
- Local Institution
-
West Seneca, New York, United States
- Local Institution
-
-
North Carolina
-
Charlotte, North Carolina, United States
- Local Institution
-
High Point, North Carolina, United States
- Local Institution
-
Morehead City, North Carolina, United States
- Local Institution
-
Salisbury, North Carolina, United States
- Local Institution
-
Winston Salem, North Carolina, United States
- Local Institution
-
-
Ohio
-
Franklin, Ohio, United States
- Local Institution
-
Newark, Ohio, United States
- Local Institution
-
Zanesville, Ohio, United States
- Local Institution
-
-
Oregon
-
Eugene, Oregon, United States
- Local Institution
-
Portland, Oregon, United States
- Local Institution
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States
- Local Institution
-
Reading, Pennsylvania, United States
- Local Institution
-
Warminster, Pennsylvania, United States
- Local Institution
-
-
Rhode Island
-
East Providence, Rhode Island, United States
- Local Institution
-
Johnston, Rhode Island, United States
- Local Institution
-
Providence, Rhode Island, United States
- Local Institution
-
-
South Carolina
-
Anderson, South Carolina, United States
- Local Institution
-
Greer, South Carolina, United States
- Local Institution
-
Mount Pleasant, South Carolina, United States
- Local Institution
-
-
Tennessee
-
Knoxville, Tennessee, United States
- Local Institution
-
Memphis, Tennessee, United States
- Local Institution
-
-
Texas
-
Fort Worth, Texas, United States
- Local Institution
-
Lubbock, Texas, United States
- Local Institution
-
San Angelo, Texas, United States
- Local Institution
-
San Antonio, Texas, United States
- Local Institution
-
-
Utah
-
Salt Lake City, Utah, United States
- Local Institution
-
-
Virginia
-
Richmond, Virginia, United States
- Local Institution
-
Virginia Beach, Virginia, United States
- Local Institution
-
-
Washington
-
Edmonds, Washington, United States
- Local Institution
-
Federal Way, Washington, United States
- Local Institution
-
Olympia, Washington, United States
- Local Institution
-
Spokane, Washington, United States
- Local Institution
-
Vancouver, Washington, United States
- Local Institution
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States
- Local Institution
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subjects with Type 2 diabetes
- Drug Naive
- HbA1c >= 7.0% and <= 10.0%
- Body Mass Index <= 41 kg/m2
- Serum TG <= 600 mg/dL
Exclusion Criteria:
- Symptomatic Type 2 diabetes
- History of bladder cancer
- History of Myocardial Infarction (MI), coronary angioplasty or bypass grafts, valvular disease or repair, unstable angina pectoris, Transient Ischemic Attach (TIA), or Cerebrovascular Accident (CVA) within 6 months, congestive heart failure (NYHA Class II and IV), uncontrolled hypertension, history of renal disease, peripheral vascular disease (PVD), pulmonary disease, gastrointestinal disease, active liver disease or endocrine disease.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Change in HbA1c from baseline to Week 24
|
Secondary Outcome Measures
Outcome Measure |
---|
Changes achieved from baseline in FPG after 24 weeks. Changes achieved from baseline in 3 hour post-prandial AUC for glucose and insulin levels after 24 weeks vs. placebo.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2003
Study Completion (Actual)
April 1, 2004
Study Registration Dates
First Submitted
October 28, 2005
First Submitted That Met QC Criteria
October 28, 2005
First Posted (Estimate)
November 1, 2005
Study Record Updates
Last Update Posted (Estimate)
April 27, 2012
Last Update Submitted That Met QC Criteria
April 26, 2012
Last Verified
April 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CV168-018
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes, Type 2
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
University of Erlangen-Nürnberg Medical SchoolCompletedType 2-diabetesGermany
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes Mellitus
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
University of Alabama at BirminghamCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Universiti Sains MalaysiaCompleted
Clinical Trials on Muraglitazar
-
Bristol-Myers SquibbCompletedDiabetes Mellitus IIUnited States, Italy, Spain, Argentina, Brazil, Mexico, Netherlands, Puerto Rico, Canada, Sweden, Australia, Poland, France, United Kingdom, Czech Republic, South Africa
-
Bristol-Myers SquibbMerck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2United States, Italy
-
Bristol-Myers SquibbCompletedDiabetes MellitusUnited States, Argentina, Brazil, Canada, Mexico, Peru, Puerto Rico, Australia, Korea, Republic of, Sweden, United Kingdom, France
-
Bristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Puerto Rico, Mexico
-
Bristol-Myers SquibbCompletedDyslipidemiaUnited States, Canada
-
Bristol-Myers SquibbCompletedMetabolics Diabetes NosUnited States, Spain, Argentina, Brazil, Germany, Mexico, Peru, Puerto Rico, Australia, Canada, Russian Federation, United Kingdom, France, Italy, Netherlands
-
Merck Sharp & Dohme LLCBristol-Myers SquibbTerminatedType 2 Diabetes Mellitus
-
Bristol-Myers SquibbMerck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2United States, Chile, Hong Kong, Argentina, Austria, Brazil, Canada, Mexico, Peru, Puerto Rico, Philippines, Thailand, Russian Federation, Poland, Germany, Taiwan, Switzerland
-
Bristol-Myers SquibbMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, Peru, Taiwan, Australia, Philippines, Thailand, Brazil, Chile, India, Russian Federation, Ukraine